Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.4255
-0.0159 (-3.60%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $26.37 million as of April 25, 2025. Its market cap has decreased by -66.69% in one year.
Market Cap
26.37M
Enterprise Value
2.39M
1-Year Change
-66.69%
Ranking
Category
Stock Price
$0.43
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $26.37M, a decrease of -89.72%. That is a compound annual growth rate of -47.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 27.35M | -6.12% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 770.65B |
| UnitedHealth Group | 386.57B |
| Johnson & Johnson | 372.27B |
| AbbVie | 318.43B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 225.12B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |